Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

P2.06-29 Expression of Estrogen Receptor Beta (ERb) and Its Prognostic Value in the Pleural Mesothelioma.

Journal of Thoracic Oncology

English

Successful Mobilization Using a Combination of Plerixafor and G-CSF in Pediatric Patients Who Failed Previous Chemomobilization With G-CSF Alone and Possible Complications of the Treatment

Journal of Hematology and Oncology

English

P1.04-13 Combining Clinical and Genomic Data for Predicting Response to Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

P3.11-07 the Quality of Screening: Comparing the Rush Lung Cancer Screening Program to the NLST and the VA Lung Cancer Screening Demonstration Project

Journal of Thoracic Oncology

English

OA10.02 Oncogene-Driven Patient Groups: A New Era for Research Partnerships

Journal of Thoracic Oncology

English

P066 a Phase I Study of Apatinib Combined With Pemetrexed and Carboplatin in Untreated EGFR-Negative Stage IV Non-Squamous NSCLC

Journal of Thoracic Oncology

English

P1.17-14 Outcomes of Hypofractionated Radiation Therapy (HFRT) With Concurrent Chemotherapy in Patients With Stage III Non Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

English

P2.03-21 Mechanistic Investigation of DRD1 in Lung Cancer

Journal of Thoracic Oncology

English

MS02.04 Optimizing Clinical Trial Designs in Immunotherapy

Journal of Thoracic Oncology

English

OA06.05 Do SBRT Planning and Delivery Factors Influence Local Control for Early Stage Non-Small Cell Lung Cancer (E-Nsclc)?

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

P2.06-29 Expression of Estrogen Receptor Beta (ERb) and Its Prognostic Value in the Pleural Mesothelioma.

Successful Mobilization Using a Combination of Plerixafor and G-CSF in Pediatric Patients Who Failed Previous Chemomobilization With G-CSF Alone and Possible Complications of the Treatment

P1.04-13 Combining Clinical and Genomic Data for Predicting Response to Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer

P3.11-07 the Quality of Screening: Comparing the Rush Lung Cancer Screening Program to the NLST and the VA Lung Cancer Screening Demonstration Project

OA10.02 Oncogene-Driven Patient Groups: A New Era for Research Partnerships

P066 a Phase I Study of Apatinib Combined With Pemetrexed and Carboplatin in Untreated EGFR-Negative Stage IV Non-Squamous NSCLC

P1.17-14 Outcomes of Hypofractionated Radiation Therapy (HFRT) With Concurrent Chemotherapy in Patients With Stage III Non Small Cell Lung Cancer (NSCLC)

P2.03-21 Mechanistic Investigation of DRD1 in Lung Cancer

MS02.04 Optimizing Clinical Trial Designs in Immunotherapy

OA06.05 Do SBRT Planning and Delivery Factors Influence Local Control for Early Stage Non-Small Cell Lung Cancer (E-Nsclc)?